-
James R. Downing, M.D., of St. Jude, elected to the American Academy of Arts and Sciences
St. Jude Children’s Research Hospital president and CEO joins the 236th class of members, which includes national and international scholars, artists, philanthropists and leaders.
-
James R. Downing, M.D., of St. Jude, to advise National Cancer Moonshot Initiative
The Blue Ribbon Panel will serve as a working group for presidentially-appointed National Cancer Advisory Board.
-
Designing an irresistible flu drug
A promising anti-influenza agent may spark the development of new medicines and combat drug resistance.
-
Problems in cellular cleanup may contribute to lupus
The most common form of the autoimmune disease lupus may be linked to defects in a cell disposal process called LAP.
-
Insights into improving pneumonia vaccines
One of the deadliest living things on Earth is the pneumococcus bacterium. Insights into how it survives and spreads have profound implications for vaccine strategies.
-
Risk factors found for leukemia treatment complication
Study finds age, ancestry and genetics can influence the risk of pancreatitis, a serious chemo side effect in acute lymphoblastic leukemia patients.
-
Diagnosing CNS-PNET tumors: Beyond the microscope
Molecular techniques may beat the microscope for diagnosing CNS-PNET, an aggressive childhood brain tumor.
From Promise, Summer 2016
More articles from this issue
-
Fighting Flu with a Vitamin Boost
Researchers investigate whether vitamins A and D can improve potency of the flu vaccine.
-
The St. Jude Melanoma Clinic
A new clinic brings families from across the nation to St. Jude to increase our knowledge about this aggressive type of skin cancer.
-
A Philosophy of Giving
For one couple, beneficence has become a way of life.
-
A Seat at the Table: Youth Help HIV/AIDS Researchers
One group of St. Jude patients helps HIV/AIDS researchers plan clinical trials and other important projects.
-
The Amazing Mr. Elephant
If one toy elephant has the power to help St. Jude, just think what you can do.
-
Gene Therapy for SCID: Thinking Outside the Bubble
Gene therapy offers hope for children born with a rare immune disease called severe combined immunodeficiency (SCID).
-
Tailored Therapy: Saving Bel's Life
A St. Jude study personalizes treatment for patients who inherit a high-risk gene variation.
-
Next-Generation Education: The St. Jude Graduate School
The new St. Jude Graduate School of Biomedical Sciences brings fresh energy to campus.
-
Vanna's Choice
When the time came to make a difference, Vanna White selected St. Jude.
-
Pomp and Circumstance: Kindergarten Graduation
Kindergarten graduates celebrate during the hospital’s 2016 graduation.